K. Kaur

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

J. Assmus, U. Waje-Andreassen, H. Ihle-Hansen, 2017, The Lancet Neurology.

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

A. Fromm, H. Næss, J. Haasz, 2022, The Lancet Neurology.